Lead Pharmacovigilance and Risk Management Guidance and Policy, European Medicines Agency, Netherlands
Priya Bahri, RPh, PostGradDipEpi, PhD, at EMA since 1996, is now EMA's Lead Pharmacovigilance and Risk Management Guidance and Policy. In this role, she also instigates research and regulatory frameworks for risk communication, stakeholder engagement for pharmacovigilance and implementation...
Read More →CM
Director, Office of Medication Error Prevention and Risk Management, OSE, CDER, FDA, United States
Claudia Manzo, PharmD is the Director of the Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology (OSE), FDA. She has over 20 years of drug safety experience and in her current role she directs review staffs (~100 FTEs) that advise and...
Read More → 
Senior Informatics Pharmacist, OMEPRM, OSE, CDER, FDA, United States
Ed Millikan, PharmD, is the Senior Informatics Pharmacist in the Division of Mitigation Assessment and Medication Error Surveillance, Office of Surveillance and Epidemiology (OSE), in FDA’s Center for Drug Evaluation and Research. With over 20 years of experience as an Informatics...
Read More →
Group Medical Director, AbbVie, United States
Barbara obtained her MD from McGill University in Montreal, Canada, and completed general Internal Medicine with specialty in Endocrinology and Metabolism at the University of Toronto. Barbara continued her training in Boston and Chicago doing basic science research and clinical endocrinology...
Read More →
Sr Director, Risk Management, Global Patient Safety, Alexion Astra Zeneca Rare Disease, United States
Meredith Smith is Risk Management Director at AstraZeneca where she is responsible for medicinal product benefit-risk management for the Alexion Rare Disease Business Unit portfolio. She is a behavioral scientist and health services researcher by training with over 15 years of experience...
Read More →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
